Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP

In patients with intermediate or high grade non-Hodgkin lymphoma (NHL), third generation chemotherapy regimens have been introduced to improve survival in comparison with the standard CHOP regimen. However, most studies have found no difference between these two treatments. We conducted a meta-analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Messori, A, Vaiani, M, Trippoli, S, Rigacci, L, Jerkeman, M, Longo, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363752/
https://www.ncbi.nlm.nih.gov/pubmed/11161392
http://dx.doi.org/10.1054/bjoc.2000.1566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363752/
https://www.ncbi.nlm.nih.gov/pubmed/11161392
http://dx.doi.org/10.1054/bjoc.2000.1566

Ejemplares similares